Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04527445 · ClinicalTrials.gov registry record · NA
Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
A NA study of Overactive Bladder and Urge Incontinence, sponsored by Loma Linda University.
- Recruiting
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT04527445: Recruiting NA study of Overactive Bladder and Urge Incontinence, sponsored by Loma Linda University.
NCT04527445 is a NA study of Overactive Bladder and Urge Incontinence that is actively recruiting participants, run by Loma Linda University. The registered enrollment target is 44 participants, below the 207-participant average among 46 other Overactive Bladder trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04527445, a NA study of Overactive Bladder and Urge Incontinence, is actively recruiting participants, sponsored by Loma Linda University.
- RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.
Primary Outcome
measure radiation exposure, milligray (mGy)
Conditions Studied
Interventions
- PROCEDURE Reduced radiation fluoroscopy
- PROCEDURE Conventional fluoroscopy
Study Locations (1)
California
- Loma Linda University Health - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT04527445 shows while recruiting
NCT04527445 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 207-participant average among 46 other Overactive Bladder trials with a reported enrollment target (79% lower).
The record links to 4 conditions, with Overactive Bladder appearing as the primary indexed condition, and to 2 interventions - of which Reduced radiation fluoroscopy is the first listed.
NCT04527445 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04527445 about?
NCT04527445 is a clinical study titled "Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement". Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.
What is the current status of trial NCT04527445?
This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2026-06. Estimated completion is 2027-06.
What conditions does trial NCT04527445 study?
This clinical trial studies the following conditions: Overactive Bladder, Urge Incontinence, Radiation Exposure, Urgency-frequency Syndrome.
What interventions are being tested in trial NCT04527445?
The interventions under investigation include: Reduced radiation fluoroscopy (PROCEDURE), Conventional fluoroscopy (PROCEDURE).
Who is sponsoring clinical trial NCT04527445?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04527445 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04527445's enrollment target sits among peer trials
44 31st of 46 higher than 16 of 46 other Overactive Bladder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overactive Bladder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead
RECRUITING · NA
-
Percutaneous Nerve Evaluation Trial Time
RECRUITING · NA
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
RECRUITING · NA
-
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
RECRUITING · NA
-
At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia